Evolus Announces Results from European Head-to-Head Filler Trial
Evolus remains on track for the global commercial launch of the first-generation Cold HA Technology in 2025.
- Evolus remains on track for the global commercial launch of the first-generation Cold HA Technology in 2025.
- The filler line will be branded Evolysse™ in the US and Estyme® in the UK and Europe.
- The Evolysse™/Estyme® Lift filler will be positioned as the most versatile and highest volume filler in the product line.
- An archived webcast can also be accessed on the Investor Relations page of the Evolus website at www.evolus.com .